USD 1.6
(6.67%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -62 Million USD | 44.08% |
2022 | -110.88 Million USD | 41.78% |
2021 | -190.45 Million USD | -109.12% |
2020 | -91.07 Million USD | -232.01% |
2019 | -27.43 Million USD | -28.57% |
2018 | -21.33 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -13.03 Million USD | 3.16% |
2024 Q2 | -8.84 Million USD | 32.11% |
2023 Q4 | -13.46 Million USD | 14.17% |
2023 FY | -62 Million USD | 44.08% |
2023 Q1 | -16.66 Million USD | -148.31% |
2023 Q2 | -15.03 Million USD | 9.79% |
2023 Q3 | -15.68 Million USD | -4.31% |
2022 Q2 | -26.74 Million USD | 19.27% |
2022 FY | -110.88 Million USD | 41.78% |
2022 Q4 | 34.49 Million USD | 236.59% |
2022 Q3 | -25.25 Million USD | 5.58% |
2022 Q1 | -33.13 Million USD | -15.64% |
2021 Q4 | -28.65 Million USD | 25.42% |
2021 Q1 | -60.49 Million USD | -36.87% |
2021 FY | -190.45 Million USD | -109.12% |
2021 Q2 | -64.47 Million USD | -6.58% |
2021 Q3 | -38.41 Million USD | 40.41% |
2020 Q3 | -29.51 Million USD | -193.79% |
2020 FY | -91.07 Million USD | -232.01% |
2020 Q4 | -44.19 Million USD | -49.75% |
2020 Q2 | -10.04 Million USD | -36.24% |
2020 Q1 | -7.37 Million USD | 3.43% |
2019 FY | -27.43 Million USD | -28.57% |
2019 Q4 | -7.63 Million USD | 0.0% |
2018 FY | -21.33 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Acutus Medical, Inc. | -81.66 Million USD | 24.07% |
Biotricity, Inc. | -14.09 Million USD | -339.944% |
Cell MedX Corp. | -142.48 Thousand USD | -43417.96% |
Dynatronics Corporation | -2.69 Million USD | -2198.497% |
Nemaura Medical Inc. | -14.14 Million USD | -338.406% |
PetVivo Holdings, Inc. | -10.95 Million USD | -466.0% |
RetinalGenix Technologies Inc. | -2.09 Million USD | -2865.581% |
Sonendo, Inc. | -60.91 Million USD | -1.786% |
Telesis Bio, Inc. | -47.72 Million USD | -29.928% |
Viveve Medical, Inc. | -22.02 Million USD | -181.505% |